The following facts and figures give a good sense of Nycomed’s size and geographic reach:
- A total of 12,500 employees
- Net turnover of € 3.2 billion in 2010
-
28th largest pharmaceutical company
- Subsidiaries in more than 70 markets – Europe, Russia/CIS, Latin America, Asia and the Middle East
- Products sold globally in over 100 countries
-
15 production facilities and 2 joint ventures in 13 countries
-
4 R&D sites, located in Europe and India
-
Top five products: Pantoprazole (gastric acid-related disorders), Actovegin® (metabolic and circulatory disturbances), Calcium D3 (osteoporosis), TachoSil® (surgical patch), Alvesco® (asthma)
-
Top five markets: Russia, Brazil, Germany, Italy, Spain